Dr. Reddy's Laboratories Ltd.(IN:DRREDDY)
₹1,377.00-9.00 (-0.65%)
IN:DRREDDY
Dr. Reddy's Laboratories Ltd. financials statements
₹1,377.00
At close:-9.00 (-0.65%)
Want to see IN:DRREDDY full AI Analyst Report?
Dr. Reddy's Laboratories Ltd. (DRREDDY) Income Statement
12 Followers
Dr. Reddy's Laboratories Ltd. Income Statement
Last quarter (Q2 2027), Dr. Reddy's Laboratories Ltd.'s total revenue was ₹86.71B, a decrease of 1.53% from the same quarter last year. In Q2, Dr. Reddy's Laboratories Ltd.'s net income was ₹9.25B. See Dr. Reddy's Laboratories Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 335.93B | ₹ 325.54B | ₹ 279.16B | ₹ 245.88B | ₹ 214.39B | |
| ₹ 177.26B | ₹ 190.43B | ₹ 163.61B | ₹ 139.34B | ₹ 113.84B | |
| ₹ 130.82B | ₹ 118.58B | ₹ 95.88B | ₹ 82.20B | ₹ 84.36B | |
| Depreciation and Amortization | ₹ 20.61B | ₹ 17.06B | ₹ 14.84B | ₹ 12.50B | ₹ 11.82B |
| ₹ 79.16B | ₹ 90.09B | ₹ 80.43B | ₹ 65.92B | ₹ 47.74B | |
| ₹ 46.44B | ₹ 71.84B | ₹ 67.73B | ₹ 57.14B | ₹ 29.48B | |
| ₹ 8.37B | ₹ 4.94B | ₹ 4.14B | ₹ 3.22B | ₹ 2.82B | |
| ₹ 54.82B | ₹ 76.78B | ₹ 71.87B | ₹ 60.37B | ₹ 32.30B | |
| ₹ 42.85B | ₹ 56.54B | ₹ 55.68B | ₹ 45.07B | ₹ 23.57B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 51.48 | ₹ 67.78 | ₹ 66.80 | ₹ 54.17 | ₹ 28.42 |
| Diluted EPS | ₹ 51.42 | ₹ 67.78 | ₹ 66.80 | ₹ 54.17 | ₹ 28.34 |
| Weighted Average Shares Outstanding | 832.36M | 834.18M | 833.54M | 831.94M | 831.67M |
| Weighted Average Shares Outstanding (Diluted) | 833.33M | 834.18M | 833.54M | 831.94M | 831.69M |
Currency in INR
